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Impact of wound blush as an angiographic end
point of endovascular therapy for patients with
critical limb ischemia
Makoto Utsunomiya, MD,a Masato Nakamura, MD,a Mami Nakanishi, MD,a Takurou Takagi, MD,a
Hidehiko Hara, MD,a Kiyoshi Onishi, MD,b Tetsuro Yamada, MD,b and Kaoru Sugi, MD,a Tokyo, Japan
Objectives: Several reports have been published of the acceptable patency and limb salvage rates after infrapopliteal
interventions for the treatment of critical limb ischemia (CLI). However, the optimal angiographic end point of
endovascular therapy (EVT) remains unclear. This study assessed the relationship between the appearance of wound
blush as an angiographic end point and the limb salvage rate in patients with CLI.
Methods: “Wound blush” was defined as contrast opacification of the vessels around the wound in digital subtraction
angiograms obtained immediately after EVT through the catheter introduced into the popliteal artery. We analyzed the data
of 77 consecutive patients (93 limbs) with ischemic ulcerations, classified as Rutherford category 5 or 6, who underwent EVT
without bypass surgery. Patients were divided into two groups depending on whether wound blush was seen in the angiogram
obtained immediately after the procedure. The freedom from amputation rate was compared between the two groups.
Results: The overall limb salvage rate was 81.7%. The limb salvage rate was significantly higher in the wound
blush-positive group than in the wound blush-negative group and remained so for at least 3 years after the EVT (96.4%
vs 56.8%, P < .001).
Conclusions: Presence of wound blush after EVT is associated with higher skin perfusion pressure, both of which are
associated with higher rates of limb salvage. Wound blush as an angiographic end point in EVT may be a novel predictor
of limb salvage in patients with CLI. (J Vasc Surg 2012;55:113-21.)
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oCritical limb ischemia (CLI), the most advanced
form of peripheral arterial disease (PAD) and usually
secondary to severe multilevel PAD, is associated with a
high rate of amputation and death. The diagnosis is
established when patients present with rest pain, ulcer-
ation, or gangrene of the leg associated with evidence of
reduced arterial blood flow to the foot.1 Prevention of
major amputation (MA) in CLI is arguably the most
important goal and is predicated on the capability for
restoring and maintaining straight-line tibial arterial
blood flow to the foot. Revascularization by bypass
surgery or endovascular therapy (EVT) plays an impor-
tant role in preventing MA, improving the quality of life,
and prolonging survival in patients with CLI. Although
bypass surgery has been the standard method of revascu-
larization because long-term patency can be achieved,
this approach also can be difficult for certain patients
because of poor surgical targets, lack of suitable con-
duits, advanced age, and presence of multiple comor-
bidities.1-3
The less invasive nature of EVT makes it an attractive
alternative to bypass surgery. Although the reliability and
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doi:10.1016/j.jvs.2011.08.001urability of EVT are limited, similar limb salvage and
ortality rates to those obtained with bypass surgery have
een reported.4 However, revascularization of the pedal
rch, even if successfully accomplished, can fail to heal
schemic lower extremity wounds.5-10 Indeed, it has been
eported that MA becomes necessary in 15% of patients
ith ischemic ulcers of the lower limbs, even in the pres-
nce of a patent bypass.11-14
In 1987, Taylor and Palmer introduced the “angio-
ome” concept, according to which the foot and ankle area
s composed of six distinct angiosomes supplied by the
osterior tibial artery (PTA), anterior tibial artery (ATA),
nd peroneal artery (PA).15,16 Some studies have suggested
he angiosome concept is clinically useful in bypass and
VT performed for limb salvage.17-20 However, direct flow
o the site of the wound based on the angiosome concept
oes not always lead to optimal lower limb perfusion. The
ngiosomes of patients with CLI are altered and mixed in a
omplex manner because of the myriad collateral circula-
ion channels.21-23
Skin perfusion pressure (SPP) has been used to assess
he perfusion of the lower limb and wounds in the lower
imb. Improvement of the SPP is correlated with the rate of
imb salvage.24 Although noninvasive angiography meth-
ds have advanced the diagnosis of peripheral arterial dis-
ase, no angiographic method has been developed to assess
he perfusion of the lower limb in an objective manner, and
he optimal angiographic end point for limb salvage is not
et clear. It would seem reasonable to consider assessment
f the angiographic status as a useful surrogate end point
or predicting limb salvage.
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January 2012114 Utsunomiya et alSimilarly to the patients with CLI, reperfusion treat-
ment is very important for patients with acute myocardial
infarction (AMI). The primary objective of reperfusion
therapies for AMI is not only restoration of blood flow in
the epicardial coronary artery but also complete reperfu-
sion of the infarcted part of the myocardium. Myocardial
blush grade (MBG) has been established as a useful
assessment of the reperfusion at the myocardial tissue
level after angioplasty for AMI and MBG after primary
angioplasty as an important predictor of infarct size and
survival.
Myocardial blush is graded on the angiograms made
immediately after primary coronary angioplasty procedure.
MBGs are defined as follows: 0, no myocardial blush or
contrast density; 1, minimal myocardial blush or contrast
density; 2, moderate myocardial blush or contrast density but
less than that obtained during angiography of a contralateral
or ipsilateral noninfarct-related coronary artery; and 3, normal
myocardial blush or contrast density, comparable with that
obtained during angiography of a contralateral or ipsilateral
noninfarct-related coronary artery. MBGs 0 or 1 are associ-
ated with larger enzymatic infarct size and lower residual left
ventricular ejection fraction.25,26
Therefore, the aim of this study was to assess the
angiographic grade of wound blush (WB) at the sites of
wounds in the lower limbs and to evaluate the correlation
between the angiographic results and the lower limb out-
comes after EVT.
METHODS
This study was performed in accordance with the dec-
laration of Helsinki, after obtaining the approval of the Ethics
Committee of Toho University Ohashi Medical Center. In-
formed consent was obtained from all the patients.
Patients. We retrospectively reviewed the records of
77 consecutive patients with CLI (93 limbs) who under-
went EVT from May 2004 to March 2010 and agreed to
attend follow-up at the Foot Care Center of Toho Univer-
sity Ohashi Medical Center. All had nonhealing ulcerations
or gangrene (Rutherford 5 or 6). We included those pa-
tients in whom successful revascularization was obtained by
EVT, defined in this study as flow from more than one
vessel to the foot without bypass. We excluded patients
with rest pain but no ulceration or gangrene (Rutherford
4), eight patients with failure of EVT, and eight patients
who could not follow the command to hold their feet still
during digital subtraction angiograms (DSA).
We routinely chose EVT as the first-line therapy for the
patients with CLI, and the clinical indication for bypass
therapy depended on the patient’s status. We attempted
complete revascularization only by EVT in such patients.
Patients with complicated lesions involving recurrent reste-
nosis or reocclusion, severe calcified lesions, or failed EVT
were considered as candidates for bypass surgery.
We divided the patients into two groups: the WB-
positive group and the WB-negative group according to
the angiographic findings immediately after the EVT.
There were 45 patients (56 limbs) in the WB-positive oroup, in which perfusion to the site of the ulcer or
angrenous area and blush around the wound were
uccessfully achieved by EVT, and 32 patients (37 limbs)
n the WB-negative group in which these angiographic
esults were not obtained.
Procedure. On admission, we confirmed whether the
emoral, popliteal, dorsalis pedis, and PTA were palpated,
nd the extent of tissue loss was recorded as part of the
reoperative vascular study. The severity of lower limb
schemia was routinely assessed by measuring the ankle-
rachial index (ABI) and the SPP. The SPP was measured
n the dorsum and sole of the foot. The lower limb arteries
ere evaluated by duplex ultrasound imaging. The indica-
ion for EVT was determined by consensus among cardio-
ascular specialists at our institution.
All EVT procedures were performed under local anes-
hesia, with the intention of establishing straight-line flow
o the foot. Decisions on which tibial vessel to treat were
ade primarily based on the angiographic appearance. If a
ingle revascularized vessel did not appear to supply the
rea of tissue loss, then intervention was attempted on
ore than one tibial vessel, with the goal of establishing
ore than one vessel runoff to the foot. If one revascu-
arized tibial vessel appeared to supply the area of the
ound, then further attempts at tibial vessel revascular-
zation were guided by the decision of the operating
nterventionist. The EVT approach for suprapopliteal le-
ions was decided at the operator’s discretion.
At the iliac level, the strategy for EVT was primary
tenting using balloon-expandable stents for the common
liac artery and self-expanding stents for the external iliac
rtery. At the femoropopliteal level, lesions were dilated for
0 seconds using an optimal balloon. A self-expanding
tent was implanted in patients who had a residual pressure
radient of 10 mm Hg, residual stenosis diameter
f 30%, or flow-limiting dissection after balloon dilata-
ion. For infrapopliteal EVT, a 0.014-inch guidewire was
dvanced into the culprit lesion, and an optimal balloon
atheter was introduced. The balloon diameter was selected
ased on the angiographic measurements of the nondis-
ased arterial segments proximal and distal to the lesion.
hen the feeding artery flow to the site of ulceration or
angrene was successfully acquired by suprapopliteal revas-
ularization, infrapopliteal lesions were not treated. Dual
ntiplatelet therapy with aspirin (100 mg/d) and ticlopi-
ine or cilostazol (200 mg/d) was started at least 1 week
efore the EVT and continued until the end of the follow-up
eriod.
Follow-up. All patients were assessed at 1 week and at
, 3, and 6 months after the EVT, and those who presented
ith open ulcers were also followed up by a plastic surgeon.
he status of the ulcer and the time until complete healing
ere recorded. The SPP was measured before and after the
VT.
Definitions. Ischemic tissue necrosis due to CLI was
efined according to the Trans Atlantic Inter-Society Con-
ensus as tissue loss associated with an ankle pressure
f 70 mm Hg or a toe pressure of 50 mm Hg. When
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Volume 55, Number 1 Utsunomiya et al 115measurements could not be obtained due to intractable rest
pain or a noncompressible artery because of severe calcifi-
cation, the SPP was measured at the dorsum and sole of the
foot. In such cases also, tissue loss with lower SPP (40
mm Hg) was defined as ischemic tissue loss. Renal insuffi-
ciency was defined as a serum creatinine of 1.5 mg/dL.
Coronary artery disease was defined as the presence of
angina pectoris or myocardial infarction, or both, and
was documented by coronary angiography. Cerebrovas-
cular disease was defined as a history of stroke, transient
ischemic attack, carotid artery revascularization, or cere-
bral hemorrhage.
WB and angiosomes. WB was judged on the angio-
grams made immediately after the EVT procedure by two
experienced investigators whowere blinded to all data apart
from the angiograms. Judging was done on cinefilm (three
frames/s) with DSA. In each patient, the best projection
was chosen to assess the microcirculation of the foot
around ulcer or gangrene. Angiographic runs had to be
long enough to allow some filling of the venous system of
the lower limb, and an adequate amount of contrast agent
(5-10 mL) to fill the lower limb arteries was injected. All
angiograms were made with a 6F to 8F guiding catheter
introduced into the popliteal artery immediately after
procedures.
WB is defined as follows:WB positive, tissue around the
wound blush or obtaining contrast opacification of the
vessels around wound; WB negative, no tissue blush
around wound or no contrast opacification of the vessels
around wound (Fig 1).
The angiosomes of the foot and ankle are defined by
the three main supplying arteries. The PTA supplies the
plantar aspect of the toes, the web spaces between the toes,
the sole of the foot, and the inside of the heel. The three
main branches of the PTA supply distinct portions of the
sole: the calcaneal branch to the heel, the medial plantar
artery to the instep, and the lateral plantar artery to the
lateral midfoot and the forefoot. The ATA continues as the
dorsalis pedis artery that supplies the dorsum of the foot.
The PA supplies the lateral border of the ankle and the
outside of the heel. Two branches of the PA supply the
anterolateral part of the ankle and the hind foot: the ante-
rior perforating branch to the anterolateral part of the
upper ankle and the calcaneal branch to the plantar aspect
of the heel.
Statistical analysis. Data analysis was performed us-
ing SPSS 19.0 software (SPSS Inc, Chicago, Ill). Kaplan-
Meier analysis and log-rank test were used for comparison
of the limb salvage rate and amputation-free survival rate
between the groups. Interobserver and intraobserver agree-
ment among the observers was determined by calculating 
coefficients. The unpaired t-test was used to compare con-
tinuous variables between the WB-positive and WB-nega-
tive groups, and the 2 test was used to compare ratios, with
statistical significance set at P  .05. Data are reported as
mean  standard deviation. aESULTS
During this study period, eight patients with CLI un-
erwent bypass surgery (six patients had received only
ypass surgery; two patients required bypass after failed
VT) and their data were excluded. The study included 77
atients (93 limbs); of these 45 (56 limbs) were categorized
nto the WB-positive group and 32 (37 limbs) into the
B-negative group. The  value for interobserver agree-
ent for the WB was 0.75 and that for intraobserver
ig 1. Example of wound blush (WB). The foot ulcer in patients
and 2 is located on the dorsal aspect of the toe. a and b, The
igital subtraction angiogram obtained immediately after the en-
ovascular therapy via the catheter introduced into the popliteal
rtery is WB-negative. Contrast opacification around the wound
ould not be obtained from the anterior tibial artery or posterior
ibial artery, despite successful treatment of both the arteries. c and
, Digital subtraction angiogram shows contrast opacification
round the wound obtained from the posterior tibial artery and is
B-positive.greement was 0.79, which showed good agreement.
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the patients are reported in Table I. The patients in the
WB-positive group were older than the patients in the
WB-negative group (75.0  11.7 vs 66.5  12.1; P 
.003), and these patients were more likely to have hyper-
Table I. Baseline patient characteristics
Variablea All
Patients, No. 77
Age, years 71.5  12.5
Male sex 52 (67.5)
Hypertension 66 (85.7)
Diabetes mellitus 52 (67.5)
Dyslipidemia 19 (24.7)
Renal insufficiency 52 (67.5)
Dialysis 44 (57.1)
Smoking 38 (49.4)
Coronary artery disease 44 (57.1)
Cerebrovascular disease 17 (22.1)
aData are shown as number (%) or mean  standard deviation.
Table II. Lower limb characteristics
Variablea All
Patients, No. 93
Rutherford class 6 33 (35.5)
Location ulcer or gangrene
Toe ATA site 46 (49.5)
Toe PTA site 31 (33.3)
Sole of foot 5 (5.4)
Dorsum of foot 3 (3.2)
Heel 5 (5.4)
Ankle 3 (3.2)
Artery feeding ulcer or gangrene
ATA 50 (53.8)
PTA 40 (43.0)
Peroneal artery 3 (3.2)
ABI before EVT 0.71  0.21
SPP before EVT, mm Hg 24.0  11.3
ABI, Ankle-brachial index; ATA, anterior tibial artery; EVT, endovascular t
aData are shown as number (%) or mean  standard deviation.
Table III. Lesion locations and the treated vessels
Variablea All
Patients, No. 93
Lesion location before EVT
Aortoiliac 24 (25.8)
Femoropopliteal 51 (54.8)
Infrapopliteal 93 (100)
Lesion treated with EVT
Suprapopliteal 52 (55.9)
Infrapopliteal 83 (89.2)
EVT, Endovascular therapy.
aData are shown as number (%).tension and to be receiving maintenance hemodialysis. bhere were no significant differences between the two
roups in the prevalence of diabetes, dyslipidemia, smok-
ng, coronary artery disease, or cerebrovascular disease.
The lower limb characteristics in the two groups are
isted in Table II. Rutherford classification and the distri-
Wound blush
PPositive Negative
45 32
75.0  11.7 66.5  12.1 .003
28 (62.2) 24 (75.0) .238
42 (93.3) 24 (75.0) .023
31 (68.9) 21 (65.6) .763
14 (31.1) 5 (15.6) .12
28 (62.2) 24 (75.0) .238
22 (48.9) 22 (68.8) .083
22 (48.9) 16 (50.0) .923
24 (53.3) 20 (62.5) .423
9 (20.0) 8 (25.0) .602
Wound blush
PPositive Negative
56 37
19 (33.9) 14 (37.8) .70
26 (46.4) 20 (54.1)
18 (32.1) 13 (35.1)
5 (8.9) 0 (0)
3 (5.4) 0 (0)
2 (3.6) 3 (8.1)
2 (3.6) 1 (2.7) .368
30 (53.6) 20 (54.1)
24 (42.9) 16 (43.2)
2 (3.6) 1 (2.7) .973
0.78  0.22 0.71  0.26 .34
26.1  12.4 20.9  8.5 .027
; PTA, posterior tibial artery; SPP, skin perfusion pressure.
Wound blush
PPositive Negative
56 37
10 (17.9) 14 (37.3)
31 (55.4) 20 (54.1)
56 (100) 37 (100) .568
27 (48.2) 25 (67.6)
51 (91.1) 32 (86.5) .821ution of the ulcers/gangrene were similar between the
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Volume 55, Number 1 Utsunomiya et al 117two groups. However, the SPP measured before the EVT
was 26.1 12.4mmHg in theWB-positive group vs 20.9
8.5 mm Hg in the WB-negative group, which was signifi-
cantly higher (P  .027). The lesion locations and treated
Fig 2. Kaplan-Meier curves for determining the limb sal
groups. The limb salvage rate was 98.2% in the WB-posi
.001), 96.4% in the WB-positive group vs 59.5% in the
WB-positive vs 56.8% in the WB-negative group at 3 yea
Table IV. Runoff status after EVT
Variablea All
Patients, No. 93
Direct flow to ulcer or gangrene 52 (55.9)
Patent runoff vessels, No.
1 38 (40.9)
2 44 (47.3)
3 11 (11.8)
SPP, mm Hg
After EVT 41.9  15.5
Difference before vs after 17.9  14.3
EVT, Endovascular therapy; SPP, skin perfusion pressure.
aData are shown as number (%) or mean  standard deviation.vessels are listed in Table III. The lesion distribution before nhe EVT was similar in the two groups. All of the patients
ad infrapopliteal lesions, and 83 limbs (89.2%) underwent
VT for infrapopliteal lesions. Of the total, 62 limbs
66.7%) had suprapopliteal lesions and underwent simulta-
ates in the wound blush (WB)-positive andWB-negative
roup vs 64.9% in the WB-negative group at 1 year (P 
egative group at 2 years (P  .001), and 96.4% in the
 .0001).
Wound blush
PPositive Negative
56 37
38 (67.9) 14 (37.8) .004
18 (32.1) 20 (54.1)
29 (51.8) 15 (40.5)
9 (16.1) 2 (5.4) .069
49.5  13.1 30.4  11.4 .001
23.4  13.6 9.5  11.0 .001vage r
tive g
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January 2012118 Utsunomiya et alThere were no significant differences in balloon size,
pressure, and guidewire used for EVT between the two
groups. The runoff status at the end of the EVT procedures
is summarized in Table IV. Direct flow to the ulcer or
gangrenous area based on the angiosome concept was
obtained in 52 limbs (55.9%). Direct flow was more likely
to be obtained in the WB-positive group, and there was
significant difference in the rate of obtainment of direct
flow between the WB-positive and WB-negative groups
(67.9% vs 37.8%, P  .004). Improvement of the SPP
measured near the ulcer was observed after the EVT in both
groups; however, the improvement was more pronounced
in the WB-positive group (23.4  13.6 vs 9.5  11.0 mm
Hg, P  .001).
Outcomes. All the patients could be monitored dur-
ing this study. The mean follow-up period was 631  423
days. By 1 year, 24% of patients needed repeat intervention
because the wound could not be healed. After 1 year, the
limb salvage rate was 98.2% in the WB-positive group and
64.9% in theWB-negative group (P .001); the rates were
96.4% and 59.5%, respectively, at 2 years (P  .001) and
96.4% and 56.8%, respectively, at 3 years (P .001; (Fig 2).
Comparison of the limb salvage rate in relation to the
obtainment of direct flow according to the angiosome
concept revealed no significant difference in the limb sal-
Fig 3. Kaplan-Meier curves for determining the limb
angiosome could be obtained and those in who direct flo
rate was 90.4% in the former group vs 78.0% in the lattevage rate between the limbs in which direct flow could be wbtained and those in which such flow could not be ob-
ained (Fig 3). Furthermore, after 1 year, the amputation-
ree survival rate was 82.1% in the WB-positive group but
as only 56.8% in the WB-negative group (P  .002); the
ates were 73.2% and 45.9%, respectively, at 2 years (P 
001) and 69.6% and 37.8%, respectively, at 3 years (P 
001; Fig 4). Thus, the limb salvage rate and amputation-
ree survival rate at 1 year after EVTwere both higher in the
B-positive group, and the high rates persisted for at least
years. There was no significant difference in the rate of
btainment of WB between patients with Rutherford 5 and
(61.7% vs 57.6%; P  .700) or in amputation-free rate
83.3% vs 78.8%; P  .587) and amputation-free survival
ate (60.0% vs 45.5%; P  .177) between patients with
utherford 5 and 6.
ISCUSSION
The results of this study showed that limb salvage in
atients with CLI was associated withWB detected onDSA
btained immediately after EVT. This suggests that assess-
ent ofWB as an angiographic end point after EVTmay be
potent and useful marker for predicting limb salvage in
atients with CLI. Recently, EVT has become the first-line
reatment approach for patients with CLI.3 Because of the
evelopment of low-profile devices and hydrophilic guide-
e rates in patients in whom direct flow based on the
the angiosome could not be obtained. The limb salvage
up at 1 year (P  .063).salvag
w toires, the success rate of EVT in patients with CLI has been
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Volume 55, Number 1 Utsunomiya et al 119increasing. Recent trials reported an excellent initial tech-
nical success rate of 90%, a low frequency of complica-
tions, and a high 1-year limb salvage rate of EVT for
CLI.27-29 In addition, infrapopliteal runoff was reported as
an independent determinant of the primary patency and
outcome after bypass surgery or EVT.30,31 Obtainment of
a straight-line flow to the ankle after EVT was associated
with limb salvage in patients with CLI. Recently, the use-
fulness of the angiosome concept was reported for guiding
surgical revascularization and devising EVT strategies for
improving the limb salvage rate.18,20 On the basis of their
experience of EVT for CLI in 203 limbs, Iida et al20
reported that the limb salvage rate was 86% in patients in
whom direct flow, based on the angiosome concept, could
be obtained compared with 69% in those in whom such
flow could not be obtained (P  .03).
They concluded that direct flow to the foot based on
the angisome concept was an important determinant of
limb salvage. This concept, if valid, strongly suggests that
the goal of EVT is not only to recanalize the vessels to the
foot but also to reperfuse the wound and allow oxygen to
be transported to the wound site. However, the infrapop-
liteal arterial vessel anatomy shows variations among pa-
Fig 4. Kaplan-Meier curves for determining the ampu
group and WB-negative group. The amputation-free su
the WB-negative group at 1 year (P  .002), 73.2% in
at 2 years (P  .001), and 69.6% in the WB-positive
.001).tients, especially in patients with CLI; alterations of the rngiosome area can occur from various factors, including
egree of ischemia, collateral connections, and patency of
he pedal arch runoff. Therefore, it is not unlikely to
eparate clearly the direct and indirect flow based on the
ngiosome concept. Accordingly, we hypothesized that
ngiographic assessment of the microcirculation of the
issue around the wound or gangrenous region may be
seful when performing EVT.
Blush grade has been well established as a qualitative
arameter for objective angiographic assessment of tissue per-
usion in the myocardium and kidney.25,26,32 Thus, we used
his concept to assess the peripheral tissue perfusion in
atients with CLI. The limb salvage rate was significantly
igher in the WB-positive group, and the SPP after EVT was
lso significantly higher in the WB-positive group than in the
B-negative group. However, there was no significant
ifference in the limb salvage rate between the patients in
hom direct flow based on the angiosome concept could
e obtained and those in whom such flow could not be
btained.
The main reason of this discrepancy was due to the
mall sample size. With further investigation, the difference
etween direct and indirect flow should be clarified. This
n-free survival rates in the wound blush (WB)-positive
l rate was 82.1% in the WB-positive group vs 56.8% in
B-positive group vs 45.9% in the WB-negative group
vs 37.8% in the WB-negative group at 3 years (P tatio
rviva
the W
groupesult may also suggest that the presence of WB is a more
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that of direct flow.
On the basis of the present outcomes, decision making
for EVT could be easier and more practical. If WB was
obtained after the EVT procedure, we could finish the
procedure even if only indirect flow was obtained. If noWB
was evident after EVT, we would treat another tibial vessel
or attempt bypass surgery.
WB was certainly obtained more easily in patients with
direct flow than without direct flow. However, this WB
could be obtained in 44% of patients without direct flow. A
high limb salvage rate could be predicted in the WB-
positive patients, even if the direct flow could not be
obtained. Thus, WB was thought not to be just a surrogate
for direct flow. Further studies, such as prospective multi-
center studies, should be needed to establish the optimal
end points of EVT.
In this study, the patients in the WB-positive group
had higher SPP scores before EVT than those in the
WB-negative group. This result suggests that WB may be
obtained only in the patients in whom the microcircula-
tion is preserved. The higher amputation-free survival
rate obtained in the WB-positive group may reflect such
a situation. Therefore, WB can be an angiographic end
point during the procedure when complicated EVT is
performed for difficult infrapopliteal lesions. The same
argument would be enhanced by including the concur-
rent cohort of patients who underwent bypass surgery;
however, we could not analyze their data due to the
incomplete data set of angiography for this group.
This study has several limitations: First, it was a single-
center, retrospective study from a prospectively maintained
database, and treatment allocation was made at the discre-
tion of the vascular specialists at our institution.
Second, the study only included patients with success-
ful intervention, which was achieved in 88.4% at our insti-
tution during the study period. If cases with unsuccessful
attempts had also been included in the analysis, the clinical
results might have been inferior.
Third, assessment by DSA was not possible for patients
who could not follow the command to hold their feet still
because of older age or abnormal involuntary movement.
Inclusion of such patients in the analysis might have yielded
inferior clinical results.
CONCLUSIONS
The presence of WB after EVT is associated with
higher SPP, both of which are associated with higher
rates of limb salvage. WB as an angiographic end point is
an important predictor for limb salvage by EVT in pa-
tients with CLI.
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